炎症性皮肤病临床实践中患者报告结局指标的共识
国际皮肤病结局测量与美国皮肤病学会通过改良德尔菲法,邀请53名利益相关者就炎症性皮肤病临床实践中的患者报告结局指标达成共识。超过70%参与者同意最小评估集包括患者目标、治疗危害和治疗反应充分性,首选5点患者整体评估(PtGA)和Skindex工具,但单独PtGA不足以全面评估患者。
要点
- 临床实践最小评估集包括患者目标、治疗危害和治疗反应充分性。
- 首选5点PtGA(0-4分)并可选勾选最严重状态。
- PtGA联合Skindex或健康相关生活质量工具可更全面评估。
核心结论
- PtGA作为独立工具不能充分捕捉患者对疾病严重程度或照护效果的评估。
- PtGA联合Skindex工具或其他健康相关生活质量测量可能提供更全面的临床评估。
研究设计与样本
- 采用改良德尔菲技术的共识构建研究,由国际皮肤病结局测量和美国皮肤病学会参与。
- 53名利益相关者(患者和提供者)参与投票。
主要发现
- 超过70%的利益相关者同意最小评估集为识别患者目标、评估治疗危害和评估治疗反应充分性。
- 最受偏好的PtGA是5点PtGA(量表0-4;0=清除,4=严重),并可选勾选最严重状态。
- 提出了一种称为轨迹测量的新指标以评估自治疗开始以来的变化。
- 利益相关者偏好Skindex工具而非PtGA和轨迹测量用于临床实践。
关键数值与推荐
- 超过70%同意最小评估包括患者目标、治疗危害和治疗反应充分性。
- 5点PtGA量表为0-4,0=清除,4=严重。
临床怎么用
- 临床中可考虑使用5点PtGA联合Skindex工具或其它健康相关生活质量测量来综合评估炎症性皮肤病患者。
局限性
- 涉及的患者和照护者数量较少。
- 并非所有条目均达成共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: International Dermatology Outcome Measures and the American Academy of Dermatology recently agreed on a physician-reported global severity measure to demonstrate quality of care in inflammatory dermatoses. OBJECTIVE: Because patient-reported outcome measures are also important, we aimed to achieve consensus on 1 of these measures for clinical practice. METHODS: Patients and providers participated in a consensus-building study involving a modified-Delphi technique. Voting was focused on identifying a minimal set of assessments for clinical practice, patient global assessments (PtGAs), Skindex instruments, and final instrument selection for quality improvement. RESULTS: Among 53 stakeholders, >70% agreed that identification of patient goals, assessment of treatment harm, and assessment of the adequacy of treatment response were the minimal assessments needed for clinical practice. The most preferred PtGA was a 5-point PtGA (scale 0-4; 0 = clear, 4 = severe) having an optional check-box for worst ever. A new metric to assess change since treatment initiation, which we called a trajectory measure, was proposed. Stakeholders preferred Skindex instruments over PtGAs and a trajectory measure for clinical practice. LIMITATIONS: A small number of patients and caregivers were involved and a consensus was not reached on all items. CONCLUSION: PtGAs as standalone measures do not adequately capture the patient's assessment of disease severity or the effect of care. The combination of a PtGA with a Skindex instrument or another measure of health-related quality of life might provide a more comprehensive evaluation of patients in clinical practice.
引用
- Perez-Chada L, Taliercio VL, Gottlieb AB, et al. Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders. J Am Acad Dermatol. 2019. PMID: 31525439. doi:10.1016/j.jaad.2019.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。